Template‐based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study

Recent studies showed the therapeutic benefit of lymphadenectomy in advanced stage urothelial carcinoma of the upper urinary tract, but there is still a lack of prospective studies and standardization of the extent of lymphadenectomy. The aim of this multi‐institutional study was to examine the role of lymphadenectomy in urothelial carcinoma of the upper urinary tract.

[1]  K. Nakagawa,et al.  Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi‐institutions , 2013, BJU international.

[2]  Richard Sylvester,et al.  European guidelines on upper tract urothelial carcinomas: 2013 update. , 2013, European urology.

[3]  F. Saint,et al.  The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy , 2013, World Journal of Urology.

[4]  J. Pow-Sang,et al.  Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma , 2012, BJU international.

[5]  K. Tanabe,et al.  Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract , 2012, International journal of urology : official journal of the Japanese Urological Association.

[6]  P. Black,et al.  The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. , 2011, Urology.

[7]  S. Shariat,et al.  No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study , 2011, World Journal of Urology.

[8]  M. Babjuk,et al.  European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. , 2011, European urology.

[9]  Y. Matsuno,et al.  Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  F. Ito,et al.  Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival , 2010, International journal of urology : official journal of the Japanese Urological Association.

[11]  J. Brierley,et al.  Urinary Bladder: (ICD‐O‐3 C67) , 2010 .

[12]  R. Bahnson,et al.  How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? , 2010, The Journal of urology.

[13]  K. Jensen,et al.  Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery , 2009, BJU international.

[14]  K. Bensalah,et al.  The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? , 2009, European urology.

[15]  K. Bensalah,et al.  Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. , 2009, The Journal of urology.

[16]  U. Capitanio,et al.  Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. , 2008, European urology.

[17]  M. Brausi,et al.  Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. , 2007, European urology.

[18]  F. Ito,et al.  Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. , 2007, The Journal of urology.

[19]  C. Foucault,et al.  Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. , 2006, Lymphology.

[20]  H. Ozen,et al.  Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. , 2006, The Journal of urology.

[21]  M. Parmar,et al.  Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. , 2005, European urology.

[22]  F. Ito,et al.  Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. , 2005, Urology.

[23]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[24]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[25]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[26]  F. Montorsi,et al.  A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. , 2010, Urology.